Literature DB >> 9054395

The 27-kDa heat shock protein facilitates basic fibroblast growth factor release from endothelial cells.

R S Piotrowicz1, J L Martin, W H Dillman, E G Levin.   

Abstract

Basic fibroblast growth factor is an important mitogenic and angiogenic factor that stimulates endothelial cell growth and migration. This hormone is not secreted via the classical vesicular pathway, and the identification of intracellular proteins that facilitate its release remains lacking. Transfection and expression of the 27-kDa human heat shock protein in bovine arterial endothelial cells doubles the rate of estrogen-induced basic fibroblast growth factor secretion, preferentially inducing the release of high molecular weight forms of the hormone. The secreted basic fibroblast growth factor is mitogenic to breast adenocarcinoma cells cultured in the conditioned medium obtained from the transfected endothelial cells. In contrast, decreasing the level of the endogenous heat shock protein homolog with an antisense vector markedly decreases basic fibroblast growth factor release. Anti-heat shock protein or anti-basic fibroblast growth factor antibodies co-precipitate both proteins from endothelial cell extracts, demonstrating a direct association between the two proteins. This interaction is likely to be an important step in the mechanism of basic fibroblast growth factor secretion.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9054395     DOI: 10.1074/jbc.272.11.7042

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Nuclear activities of basic fibroblast growth factor: potentiation of low-serum growth mediated by natural or chimeric nuclear localization signals.

Authors:  M Arese; Y Chen; R Z Florkiewicz; A Gualandris; B Shen; D B Rifkin
Journal:  Mol Biol Cell       Date:  1999-05       Impact factor: 4.138

2.  Novel mechanism for gonadotropin-releasing hormone neuronal migration involving Gas6/Ark signaling to p38 mitogen-activated protein kinase.

Authors:  Melissa P Allen; Daniel A Linseman; Hiroshi Udo; Mei Xu; Jerome B Schaack; Brian Varnum; Eric R Kandel; Kim A Heidenreich; Margaret E Wierman
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

3.  High molecular weight FGF2 isoforms demonstrate canonical receptor-mediated activity and support human embryonic stem cell self-renewal.

Authors:  Denis Kole; Alexandra Grella; David Dolivo; Lucia Shumaker; William Hermans; Tanja Dominko
Journal:  Stem Cell Res       Date:  2017-04-18       Impact factor: 2.020

4.  Anti-inflammatory cytokine interleukin-19 inhibits smooth muscle cell migration and activation of cytoskeletal regulators of VSMC motility.

Authors:  Khatuna Gabunia; Surbhi Jain; Ross N England; Michael V Autieri
Journal:  Am J Physiol Cell Physiol       Date:  2011-01-05       Impact factor: 4.249

5.  The influence of FGF2 high molecular weight (HMW) isoforms in the development of cardiac ischemia-reperfusion injury.

Authors:  Siyun Liao; Janet R Bodmer; Mohamad Azhar; Gilbert Newman; J Douglas Coffin; Thomas Doetschman; Jo El J Schultz
Journal:  J Mol Cell Cardiol       Date:  2010-01-29       Impact factor: 5.000

Review 6.  High molecular weight FGF2: the biology of a nuclear growth factor.

Authors:  K Chlebova; V Bryja; P Dvorak; A Kozubik; W R Wilcox; P Krejci
Journal:  Cell Mol Life Sci       Date:  2009-01       Impact factor: 9.261

7.  Thrombin cleaves the high molecular weight forms of basic fibroblast growth factor (FGF-2): a novel mechanism for the control of FGF-2 and thrombin activity.

Authors:  P-J Yu; G Ferrari; L Pirelli; A C Galloway; P Mignatti; G Pintucci
Journal:  Oncogene       Date:  2007-10-29       Impact factor: 9.867

8.  Basic fibroblast growth factor impact on retinoblastoma progression and survival.

Authors:  Colleen M Cebulla; Maria-Elena Jockovich; Yolanda Piña; Hinda Boutrid; Armando Alegret; Amy Kulak; Abigail S Hackam; Sanjoy K Bhattacharya; William J Feuer; Timothy G Murray
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-07-09       Impact factor: 4.799

9.  Heat shock protein 27 as a new therapeutic target for radiation sensitization of head and neck squamous cell carcinoma.

Authors:  Elie Hadchity; Marie-Thérèse Aloy; Christian Paulin; Emma Armandy; Emmanuel Watkin; Robert Rousson; Martin Gleave; Olivier Chapet; Claire Rodriguez-Lafrasse
Journal:  Mol Ther       Date:  2009-05-12       Impact factor: 11.454

10.  Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer.

Authors:  Oddbjørn Straume; Takeshi Shimamura; Michael J G Lampa; Julian Carretero; Anne M Øyan; Di Jia; Christa L Borgman; Margaret Soucheray; Sean R Downing; Sarah M Short; Soo-Young Kang; Souming Wang; Liang Chen; Karin Collett; Ingeborg Bachmann; Kwok-Kin Wong; Geoffrey I Shapiro; Karl Henning Kalland; Judah Folkman; Randolph S Watnick; Lars A Akslen; George N Naumov
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.